Psychedelic Stock Gainers And Losers From January 24, 2022
GAINERS:
Field Trip Health (NASDAQ:FTRP) shares closed up 6.45% at $1.98
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS:
Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25
Psychedelic Stock Gainers And Losers From January 18, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07
Ketamine Therapy Shows Potential In Treatment Of Alcohol Use Disorder, New Study Finds
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted therapy for the treatment of alcohol use disorder.
Psyched: MindMed’s MDMA Program For Autism, Small Pharma’s New Patent, NovaMentis’ Orphan Drug Designation
The Week In Psychedelics:
MindMed Launches MDMA Program For Social Anxiety And Autism
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
The Week In Psychedelics
British Prime Minister Boris Johnson To Consider Psilocybin Legalization
There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF
On Thursday, AdvisorShares launched the country’s first actively managed ETF covering the psychedelics sector.